Cognitive Challenges in Cancer Patients

Understanding Cognitive Impairments

Many cancer patients experience cognitive difficulties as their illness progresses. A recent study suggests that aspirin may help mitigate these cognitive issues in mice with cancer. Research indicates that nearly 50% of cancer patients with solid tumors encounter cognitive problems, including challenges with learning, concentration, and memory. Notably, some of these cognitive impairments can persist for decades after successful cancer treatment. Initially, medical professionals attributed these issues primarily to chemotherapy; however, it is now recognized that cognitive problems can begin even before treatment starts.

Research on Inflammation and Cognition

A team of Australian researchers has been investigating the cognitive challenges linked to cancer. They hypothesized that inflammation caused by tumors might contribute to these impairments. To explore this, they examined whether ordinary aspirin, known for its anti-inflammatory properties, could be beneficial. Their findings were recently published in the scientific journal PLOS One.

Study Methodology and Findings

Testing Memory in Mice

In their study, researchers injected breast cancer tumor cells into the mammary glands of female mice. Two weeks post-injection, the mice began developing measurable breast tumors. A key aspect of cognitive ability is the capacity to remember new information. The researchers evaluated the mice’s ability to recognize previously shown objects, comparing the memory of those injected with tumor cells to that of healthy mice injected with water.

Early Signs of Cognitive Impairment

The results revealed that memory impairment in mice occurred within one week following the tumor cell injections, even before significant tumor growth was noted. Furthermore, injecting mice with chemicals produced by tumor cells, rather than the tumor cells themselves, also led to memory deficits. This observation led researchers to conclude that the chemicals released by tumor cells, rather than the tumors themselves, might be responsible for the cognitive issues.

Role of Inflammation in Cognitive Problems

Investigating the Effects of Aspirin

Tumors generate various pro-inflammatory substances, which may contribute to cognitive problems in the mice. To test this theory, researchers added aspirin to the drinking water of the mice, providing an equivalent dose of 100 mg/day for humans—considered a low dose. The results showed that aspirin successfully prevented memory issues in mice injected with tumor cells, while having no effect on tumor size.

Limitations and Implications for Human Patients

Despite promising results, the study has limitations. The most severe memory issues occurred within days of the tumor cell injections, and symptoms appeared to lessen or resolve within two weeks. This discrepancy raises questions about the comparability of these findings to long-term cognitive impairments observed in human patients. Additionally, the mice received aspirin 36 hours before tumor cell injection, which is not feasible for human patients since treatment cannot commence until cancer is diagnosed.

Furthermore, successful outcomes in mice do not guarantee similar results in humans. Clinical trials are necessary to determine the efficacy of aspirin in oncology settings and to ensure it does not interact negatively with other cancer treatments.

Conclusion

Although there are limitations to these findings, the safety and low cost of low-dose aspirin present an opportunity for its potential integration into cancer treatment protocols, pending confirmation from clinical trials.

Reference

Walker, A. K., Chang, A., Ziegler, A. I., Dhillon, H. M., Vardy, J. L., & Sloan, E. K. (2018). Low dose aspirin blocks breast cancer-induced cognitive impairment in mice. PLOS ONE, 13(12), e0208593.